Is it Safe to Buy Salesforce Stock Right Now? | CRM STock Analysis
Summary
Parkev argues that Salesforce (CRM) presents a compelling buying opportunity based on strong management projections and operational improvements. Management anticipates re-accelerating revenue growth in the second half of 2027 and beyond, with a reaffirmed goal of $63 billion in revenue by 2030. Operating profit margins are expected to reach around 34% for the second half and the full current fiscal year.
Parkev highlights that Salesforce has effectively addressed investor concerns regarding slowing revenue growth and potential disruption from artificial intelligence. While growth had dipped below 10%, it rebounded to 13% in the last quarter and is projected to accelerate further. Management asserts that Salesforce is not being disrupted by AI but rather integrating it, upselling AI-powered services to customers, and thereby increasing the average selling price per seat.
The company has also significantly improved its operating profit margins, reaching 34% in the last quarter, a substantial increase from the 21.5% average over the prior 12 months. This improvement is attributed to a successful restructuring in 2022, which prepared the company for a potential recession and led to better cost control. Salesforce has also achieved its highest-ever return on invested capital at 12.7% over the last twelve months.
Parkev notes that despite a significant stock price rally from below $150 to over $232, the current valuation, with a forward price-to-earnings ratio of 14.6, remains near the lowest levels observed in recent years for this metric. Parkev's updated discounted cash flow valuation estimates Salesforce's fair value at $280 per share, indicating an approximate 20% upside potential from the current market price of $233 over the next 12 to 18 months.
Mentioned Stocks
Reasoning: Parkev states that Salesforce management has addressed concerns about AI disruption and slowing growth, projecting re-accelerated revenue growth by H2 2027 and reaffirming a $63 billion revenue target by 2030. Operating margins are robust at 34%, driven by successful restructuring. Parkev notes that the company is effectively integrating AI and upselling services, increasing customer value. Despite a recent stock price increase to over $232, the forward P/E of 14.6 is still near historical lows. Parkev's discounted cash flow valuation pegs the fair value at $280 per share, suggesting approximately 20% upside potential from the current market price of $233 over the next 12 to 18 months, leading him to reiterate his buy rating.